Steve Aselage

Companies

• BioCryst PharmaceuticalsBoard member Jan 8, 2019 to Jun 14, 2024¹
• Opexa TherapeuticsBoard member Sep 21, 2017 to Nov 20, 2023²
• Travere Therapeutics, Inc.Board member Dec 27, 2013 to May 12, 2022³
• Travere Therapeutics, Inc.Chief executive officer Nov 10, 2014 to Feb 13, 2019⁴
• Travere Therapeutics, Inc.Chief operating officer Jun 3, 2014 to Jun 3, 2014⁵
• Travere Therapeutics, Inc.President Jun 3, 2014 to Jun 3, 2014⁵
• BioMarin PharmaceuticalSVP, Global Commercial Ops Jan 10, 2006 to Jul 5, 2012⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX166,419 shares⁷$8.8M at $53.15May 11, 2022
• BioCryst Pharmaceuticals BCRX72,659 shares⁸$566.0K at $7.79Jun 14, 2024
• OTOpexa Therapeutics0 shares⁹Nov 17, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 12, 2024Granted 6,820 shares of BioCryst Pharmaceuticals⁸
• May 24, 2024Bought 2,500 shares at $6.40 of BioCryst Pharmaceuticals¹⁰
• Nov 17, 2023Returned to company 483,741 shares of Opexa Therapeutics⁹
• Jun 13, 2023Granted 16,745 shares of BioCryst Pharmaceuticals¹¹
• Nov 29, 2022Bought 409,836 shares at $1.22 of Opexa Therapeutics¹²
• Jun 7, 2022Granted 12,866 shares of BioCryst Pharmaceuticals¹³
• May 31, 2022Granted 569 shares at $9.31 of BioCryst Pharmaceuticals¹⁴
• May 11, 2022Sold 2,575 shares at $21.92 of Travere Therapeutics, Inc.⁷
• Feb 28, 2022Granted 301 shares at $16.61 of BioCryst Pharmaceuticals¹⁵
• Dec 10, 2021Bought 7,984 shares at $2.04 of Opexa Therapeutics¹⁶
• Dec 9, 2021Bought 2,016 shares at $2.15 of Opexa Therapeutics¹⁶
• Nov 30, 2021Granted 414 shares at $12.06 of BioCryst Pharmaceuticals¹⁷
• Nov 16, 2021Sold 31,800 shares at $29.39 of Travere Therapeutics, Inc.¹⁸
• Nov 5, 2021Sold 10,000 shares at $26.23 of Travere Therapeutics, Inc.¹⁹
• Nov 5, 2021Exercised options 10,000 shares at $16.23 of Travere Therapeutics, Inc.¹⁹
• Nov 2, 2021Sold 3,500 shares at $30.00 of Travere Therapeutics, Inc.²⁰
• Nov 1, 2021Sold 5,000 shares at $29.48 of Travere Therapeutics, Inc.²⁰
• Oct 7, 2021Sold 32,000 shares at $26.26 of Travere Therapeutics, Inc.²¹
• Oct 7, 2021Sold 28,000 shares at $26.23 of Travere Therapeutics, Inc.²¹
• Oct 7, 2021Exercised options 60,000 shares at $16.23 of Travere Therapeutics, Inc.²¹
• Jul 16, 2021Gift 3,000 shares of Travere Therapeutics, Inc.²⁰
• Jul 16, 2021Gift 3,000 shares of Travere Therapeutics, Inc.²⁰
• Feb 4, 2021Gift 25,000 shares of Travere Therapeutics, Inc.²⁰
• Feb 4, 2021Gift 25,000 shares of Travere Therapeutics, Inc.²⁰